Latest News
Latest News
Dobson | DaVanzo Awarded Medicare Part D Drug Manufacturer Program Data Support
We are pleased to announce that Dobson | DaVanzo was recently awarded the Medicare Part D Manufacturer Discount Program Data Support contract with CMS. This project supports CMS through analyses related to the Manufacturer Discount Program, which replaced the Coverage Gap Discount Program as mandated by the Inflation Reduction Act of 2022.
Unlocking Economic and Safety Benefits: The Case for Microprocessor Knees
Dobson | DaVanzo is proud to share a recent study conducted by our team, published in Prosthetics and Orthotics International, which highlights the impact of providing microprocessor knees (MPKs) to Medicare Fee-for-Service (FFS) K2 beneficiaries (those with above-knee or knee disarticulation amputations who have the ability or potential for ambulation to traverse low level environmental barriers such as curbs, stairs, or uneven surfaces).
Navigating Policy Changes with Data-Driven Insights
With the recent changes in the Administration, shifts in health policy priorities are inevitable. For organizations impacted by these developments, understanding the implications and leveraging data to adapt is more crucial than ever. At Dobson | DaVanzo, we specialize in health policy and economic analyses, offering comprehensive data analytics and policy insights to help our clients make informed decisions. Whether you need to evaluate the effects of proposed regulations, assess financial implications, or identify trends in healthcare access, our team provides the expertise and tools to translate complex data into actionable strategies.
Blog
Dobson|DaVanzo’s Data Analytics for Medicare Episode-Based Payment Models
Tuesday, March 30, 2021 | by Randy Haught
Using CMS Innovation Award Data, Dobson|DaVanzo is helping physicians and physician group practices “deep dive” into the complex world of MIPS VBP cost efficiency measures by dissecting risk-adjusted Medicare spending during episodes of care for 18 medical conditions/surgical procedures by clinical theme, type of service, and episode period (pre-, intra-, and post-trigger periods) compared to peer-group benchmarks. This allows providers to easily identify areas for improvement. Our monthly and quarterly data updates provide timely information that allows providers to continually monitor their performance trend overtime.
How Much of the Herd Has Some Immunity?
Friday, February 26, 2021 | by Alex Hartzman
COVID-19 cases are currently on the decline in the U.S. and effective vaccines have been developed, approved and are being distributed at record pace – all cause for celebration. However, new variants and societal fatigue are continuing dangers to the health and well-being of Americans as the government and healthcare industry race to vaccinate and protect people from the novel pathogen. As we complete our first full year living in the COVID-19 public health emergency, this blog explores two questions worth asking:
- How far are we into this pandemic (in terms of herd immunity); and
- What are our policy options to take advantage of this recent decline in cases and steadily increasing availability of vaccines?
Publications
Dobson | DaVanzo's principals are committed to being on the cutting-edge of healthcare research. Backed by the team's decades of experience, Dobson | DaVanzo's numerous studies of hospitals, finance, Medicare provider payments, and preventive healthcare services have been published in a variety of journals and are used as a resource by researchers, policy makers, legislators and others.